These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
225 related articles for article (PubMed ID: 11436350)
21. Transgenic mouse models of neurodegenerative disease caused by CAG/polyglutamine expansions. Bates GP; Davies SW Mol Med Today; 1997 Nov; 3(11):508-15. PubMed ID: 9430787 [TBL] [Abstract][Full Text] [Related]
22. Cell death triggered by polyglutamine-expanded huntingtin in a neuronal cell line is associated with degradation of CREB-binding protein. Jiang H; Nucifora FC; Ross CA; DeFranco DB Hum Mol Genet; 2003 Jan; 12(1):1-12. PubMed ID: 12490527 [TBL] [Abstract][Full Text] [Related]
23. Surface plasmon resonance characterization of specific binding of polyglutamine aggregation inhibitors to the expanded polyglutamine stretch. Okamoto Y; Nagai Y; Fujikake N; Akiko Popiel H; Yoshioka T; Toda T; Inui T Biochem Biophys Res Commun; 2009 Jan; 378(3):634-9. PubMed ID: 19061859 [TBL] [Abstract][Full Text] [Related]
25. [Therapeutic strategies for the polyglutamine diseases]. Nagai Y; Popiel HA; Fujikake N; Toda T Brain Nerve; 2007 Apr; 59(4):393-404. PubMed ID: 17447526 [TBL] [Abstract][Full Text] [Related]
26. Polyglutamine diseases: a transcription disorder? Okazawa H Cell Mol Life Sci; 2003 Jul; 60(7):1427-39. PubMed ID: 12943229 [TBL] [Abstract][Full Text] [Related]
27. Allele-selective suppression of mutant genes in polyglutamine diseases. Liu CR; Cheng TH J Neurogenet; 2015; 29(2-3):41-9. PubMed ID: 26174158 [TBL] [Abstract][Full Text] [Related]
28. Identification of ter94, Drosophila VCP, as a modulator of polyglutamine-induced neurodegeneration. Higashiyama H; Hirose F; Yamaguchi M; Inoue YH; Fujikake N; Matsukage A; Kakizuka A Cell Death Differ; 2002 Mar; 9(3):264-73. PubMed ID: 11859409 [TBL] [Abstract][Full Text] [Related]
29. Analyzing the aggregation of polyglutamine-expansion proteins and its modulation by molecular chaperones. Kubota H; Kitamura A; Nagata K Methods; 2011 Mar; 53(3):267-74. PubMed ID: 21195182 [TBL] [Abstract][Full Text] [Related]
30. Prevention of polyglutamine oligomerization and neurodegeneration by the peptide inhibitor QBP1 in Drosophila. Nagai Y; Fujikake N; Ohno K; Higashiyama H; Popiel HA; Rahadian J; Yamaguchi M; Strittmatter WJ; Burke JR; Toda T Hum Mol Genet; 2003 Jun; 12(11):1253-9. PubMed ID: 12761040 [TBL] [Abstract][Full Text] [Related]
36. Conformational changes and aggregation of expanded polyglutamine proteins as therapeutic targets of the polyglutamine diseases: exposed beta-sheet hypothesis. Nagai Y; Popiel HA Curr Pharm Des; 2008; 14(30):3267-79. PubMed ID: 19075705 [TBL] [Abstract][Full Text] [Related]
37. Caspases that are activated during generation of nuclear polyglutamine aggregates are necessary for DNA fragmentation but not sufficient for cell death. Kouroku Y; Fujita E; Urase K; Tsuru T; Setsuie R; Kikuchi T; Yagi Y; Momoi MY; Momoi T J Neurosci Res; 2000 Nov; 62(4):547-56. PubMed ID: 11070498 [TBL] [Abstract][Full Text] [Related]
38. Polyglutamine expansion reduces the association of TATA-binding protein with DNA and induces DNA binding-independent neurotoxicity. Friedman MJ; Wang CE; Li XJ; Li S J Biol Chem; 2008 Mar; 283(13):8283-90. PubMed ID: 18218637 [TBL] [Abstract][Full Text] [Related]
39. Neurodegeneration. A glutamine-rich trail leads to transcription factors. Freiman RN; Tjian R Science; 2002 Jun; 296(5576):2149-50. PubMed ID: 12077389 [No Abstract] [Full Text] [Related]
40. Mechanisms of RNA-induced toxicity in CAG repeat disorders. Nalavade R; Griesche N; Ryan DP; Hildebrand S; Krauss S Cell Death Dis; 2013 Aug; 4(8):e752. PubMed ID: 23907466 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]